戻る Agenda
Oral Poster Session 5 - Translational Medicines and Science & Data and Data Standards Content Hub
Learning Objective : Show the dependency between level of Complexity, level of Compliance and the Total Cost of Ownership trends and compare the Integrated with the Integral Approach
Speaker(s)
Turn Compliance into Value – Decrease Complexity, Increase Compliance and Reduce Total Costs of Ownership
Romuald Braun, MS, MSC, RAC
Uanotau Gmbh, Switzerland
Managing Director
An Assessment of Real-World Data, Artificial Intelligence, and their Use in Drug Development
Kenneth Hu, PHARMD, MBA
Bristol Myers Squibb, United States
Senior Manager (US Reg Lead), Global Regulatory Strategy & Policy, Oncology
Text Mining Discharge Summaries of Hospital Electronic Medical Records to Detect Adverse Drug Reactions
Sreemanee Raaj Dorajoo, PHD
Health Sciences Authority (HSA), Singapore
Senior Data Analyst, Vigilance and Compliance Branch